ARMD – Age Related Macular Degeneration
The retina is many layers of specialized cells inside the eyeball. The macula is the central area of the retina. Through the macula we get the sharp images, colors and details of objects.
In some people the cells of the macula become degenerated and the result is a loss of visual function (blurring of images), and progressive central loss vision.
All persons over 60 years of age are subject to this problem, but the disease does not manifest itself equally for everyone. Some cases are more serious than others. This happened by individual influences (genetic and environment factors).
Modern medicine is well equipped for an efficient diagnosis on examination with photography methods using angiography and OCT (optical tomography), the medical expert should be prepared to classify the lesions and propose the most appropriate treatment for each case.
One form of treatment currently used is the use Bevacizumab (Avastin) and Ranabizumab (Lucentis). These are drugs that inhibit the formation of the lesion. However, not all cases get better with these substances and not all patients can be treated with Avastin and Lucentis.
Another form of treatment for wet ARMD is photodynamic therapy (PDT). This procedure uses a substance called Visudyne associated with application of a laser stimulator, resulting in lesion regression.
Also as part of therapies is Triamcinolone, used normally associated with other forms of treatment.
The guidance of an experienced retina specialist is the main factor to obtain the best result of existing treatments